 |
|
Long-term estrogen therapy linked to breast cancer risk
May 09, 2006Long-term estrogen therapy may be related to a higher risk of breast cancer among postmenopausal women who have had a hysterectomy, according to an article in the May 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Previous studies have linked the use of hormone therapy to breast cancer among postmenopausal women, but have primarily focused on the hormone combination of estrogen plus progestin, according to background information in the article. Recently released results from the Women's Health Initiative (WHI), a large clinical trial of hormone therapy, found no significant link between estrogen therapy and breast cancer in women who took the hormone for seven years.
Wendy Y. Chen, M.D., M.P.H., Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, and colleagues evaluated women who were part of the Nurses' Health Study, a group of female nurses that have been followed since 1976. In 1980, 11,508 women from the study were postmenopausal and had had a hysterectomy. Every two years the researchers enrolled all the additional women who become postmenopausal and had a hysterectomy, so 28,835 women were included by the end of the study in 2002. Women were asked by questionnaire every two years if they used hormones and whether they had developed breast cancer. For women who developed breast cancer, the researchers obtained permission to review the women's medical records, which they used to record the hormone receptor information. Tumors were classified as positive or negative for estrogen receptor or progesterone receptor based on how they responded to specific hormonal therapies.
Throughout the study period, 934 invasive breast cancers developed, 226 among women who had never used hormones and 708 among women who were using estrogen at the time. The longer a woman used estrogen, the higher her risk of breast cancer. Those who had been taking estrogen for fewer than 10 years did not appear to have a higher risk than those who had never taken hormones, but those who had been taking estrogen for more than 20 years had a significantly increased risk. The association was strongest for cancers that were estrogen receptor positive and progesterone receptor positive. The results were similar when the researchers evaluated only women who were older than age 60; only women who had begun estrogen therapy after reaching age 50; and only women who were at least age 50 and had undergone a hysterectomy, even if they had not gone through menopause.
"In conclusion, we found that estrogen therapy was associated with an increased risk of breast cancer with longer-term use," the authors write. "Although current use of estrogen therapy for less than 10 years was not associated with a statistically significant increase in breast cancer risk, the WHI has shown an increased risk of stroke and deep-vein thrombosis in the same time period. Women who take estrogen therapy for prevention or treatment of osteoporosis typically require longer-term treatment and should thus explore other options, given the increased risk of breast cancer with longer-term use."
JAMA and Archives Journals
Throughout the study period, 934 invasive breast cancers developed, 226 among women who had never used hormones and 708 among women who were using estrogen at the time. The longer a woman used estrogen, the higher her risk of breast cancer. Those who had been taking estrogen for fewer than 10 years did not appear to have a higher risk than those who had never taken hormones, but those who had been taking estrogen for more than 20 years had a significantly increased risk. The association was strongest for cancers that were estrogen receptor positive and progesterone receptor positive. The results were similar when the researchers evaluated only women who were older than age 60; only women who had begun estrogen therapy after reaching age 50; and only women who were at least age 50 and had undergone a hysterectomy, even if they had not gone through menopause.
"In conclusion, we found that estrogen therapy was associated with an increased risk of breast cancer with longer-term use," the authors write. "Although current use of estrogen therapy for less than 10 years was not associated with a statistically significant increase in breast cancer risk, the WHI has shown an increased risk of stroke and deep-vein thrombosis in the same time period. Women who take estrogen therapy for prevention or treatment of osteoporosis typically require longer-term treatment and should thus explore other options, given the increased risk of breast cancer with longer-term use."
JAMA and Archives Journals
Estrogen Therapy Current Events and Estrogen Therapy News RSSLow-dose estrogen shown safe and effective for metastatic breast cancer
When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment.
Mayo Clinic researchers say agent provides treatment option for women with hot flashes
A pill used for nerve pain offers women relief from hot flashes, Mayo Clinic researchers report at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).
New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests.
Hormone therapy associated with reduced colorectal cancer risk
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
Estrogen therapy could be dangerous for women with existing heart risk
Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests.
New predictive tool can help determine treatment of breast cancer patients
A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with early stage breast cancer - a low PEPI (preoperative endocrine prognostic index) score could show that they have little risk of relapse and can safely avoid chemotherapy after surgery.
Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis
Cancer patients with low socioeconomic status (SES) have more advanced cancers at diagnosis, receive less aggressive treatment, and have a higher risk of dying in the five years following cancer diagnosis, according to a new study.
Estrogen therapy helps or hurts the brain depending on reproductive status
Estrogen therapy may limit stroke damage if started close to, but not long after reproductive cycles are over, according to a new animal study. The results were presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.
Popular osteoporosis drugs triple risk of bone necrosis
A University of British Columbia and Vancouver Coastal Health Research Institute study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain.
Effects of progesterone on Alzheimer's disease
The first study on progesterone and Alzheimer's disease has found no clear preventive benefit for the widely prescribed hormone in an animal model.
More Estrogen Therapy Current Events and Estrogen Therapy News Articles
 |
The Estrogen Alternative: Natural Hormone Therapy with Botanical Progesterone by Raquel Martin (Author), D.C., Judi Gerstung (Contributor) Includes the latest research on how to combat osteoporosis, endometriosis, heart disease, PMS, fibroids, and breast, ovarian, and uterine cancer. * A must-read for any woman taking synthetic hormones for infertility or birth control, PMS, or menopause. * Explains the most recent research on diet, endometriosis, osteoporosis, and breast, ovarian, and uterine cancer. * Previous editions have sold more than 50,000 copies. In this revised and expanded third edition, Raquel Martin offers the most up-to-date information on how botanical progesterone therapy can offer safe, natural relief for many of the discomforts women face from hormone deficiency, including PMS, menstrual irregularity, infertility, depression, uterine fibroids, and the symptoms of ... |
 |
Estrogen/Estriol (Bio-identical) Fragrance Free Creme 2 oz. Jar by Radiant Laboratories - Made In USA Paraben-Free and Unscented. Menopausal Hot Flashes? Night Sweats? Trouble Sleeping? Replenish Your Estrogen Naturally and Safely. Get your life back! Estriol Has Been Used in Europe for Years. Bio-identical Hormones Are Safe and Effective. Non Prescription Bio-identical Natural Estrogen (Estriol Usp) Not to Be Confused with Phyto-estrogens. Bio-identical Hormones Are Safe for Women Help Relieve Menopause Symptoms. Estriol is not a phyto estrogen. Don't confuse phyto estrogens with pure natural estriol USP. The natural estrogen, estriol USP, is made the same way natural progesterone USP is made. Sterol analogues found in many varieties of plants are combined with specific bacteria and the resulting hormone is bio identical in chemical structure to the hormone produced by the human body.... |
 |
Enzymatic Therapy Protective Breast Formula (60 Tablets) by Enzymatic Dietary supplement with natural ingredients to promote breast health. |
 |
Risks and Benefits of Menopause & Hormones Do the risks and benefits of initiating or continuing menopausal hormones (estrogens and progestins) differ in women of menopausal age (40 - 55) versus older women? What are the alternatives to taking estrogen to relieve menopausal symptoms, e.g. hot flushes/night sweats, or prevent bone loss? This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Redefine Nutrition Revolution by Redefine Nutrition PCT Revolution is the most pivotal advancement in Post Cycle Therapy ever introduced. Combining five essential pieces to the PCT puzzle, Redefine Nutrition has raised the bar in Legal Post Cycle Therapy with the introduction of PCT Revolution. Taken as directed, PCT Revolution will revitalize testosterone levels leading to increased energy, strength, and sex drive. |
|
Low-dose estrogen boosts BMD in older women: small study.(Women's Health): An article from: Family Practice News by Heidi Splete (Author) This digital document is an article from Family Practice News, published by International Medical News Group on October 1, 2003. The length of the article is 540 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Low-dose estrogen boosts BMD in older women: small study.(Women's Health) Author: Heidi Splete Publication: Family Practice News (Magazine/Journal) Date: October 1, 2003 Publisher: International Medical News Group Volume: 33 Issue: 19 Page: 54(1) Distributed by Thomson... | |
 |
The Estrogen Elixir: A History of Hormone Replacement Therapy in America by Elizabeth Siegel Watkins (Author) In the first complete history of hormone replacement therapy (HRT), Elizabeth Siegel Watkins illuminates the complex and changing relationship between the medical treatment of menopause and cultural conceptions of aging. Describing the development, spread, and shifting role of HRT in America from the early twentieth century to the present, Watkins explores how the interplay between science and society shaped the dissemination and reception of HRT and how the medicalization -- and subsequent efforts toward the demedicalization -- of menopause and aging affected the role of estrogen as a medical therapy. Telling the story from multiple perspectives -- physicians, pharmaceutical manufacturers, government regulators, feminist health activists, and the media, as well as women as... |
 |
Menopause and Estrogen: Natural Alternatives to Hormone Replacement Therapy, 2nd Edition by Ellen Brown (Author), Lynn Walker (Author) One of the most hard-hitting menopause books in its critique of the way the medical establishment views and treats menopause, its purpose is two-fold. Firstly, to tell the "real story" about hormone replacement therapy, its dangers, and why doctors are pushing it; and secondly to offer alternative treatments based on looking at the body and aging from the point of view of health, not pathology. This is an incredibly important book for transforming the myths of aging and bringing women's healing back into the hands of women. |
 |
Caring for the Surgically Menopausal Patient: A Physiological Renaissance Also With: NCI (Producer), Dr. Gloria Bachmann (Host) Caring for the Surgically Menopausal Patient is a highlights Videostat produced by Nelson Communciations, Inc. A symposium, chaired by Dr. Gloria Bachmann, covered the Pre, Peri and Post operative management issues of the surgically menopausal patient. This video cover the key highlights of the meeting. 1) Pre-Operative and Patient Evaluation 2) Hysterectomies - Maximize Patient Comfort and Minimize Cost 3) Managing Post-Operative Patients. |
 |
Confessions of an estrogen evangelist: Setting the record straight on estrogen replacement therapy by Joyce A. Kakkis (Author), David Paul Green (Author) |
| © 2009 BrightSurf.com |